Screening Tests to identify poor Outcomes in Pregnancy (STOP) Study
- Conditions
- PreeclampsiaSmall for gestational age birthPreterm birthGestational diabetes mellitusReproductive Health and Childbirth - Fetal medicine and complications of pregnancy
- Registration Number
- ACTRN12614000985684
- Lead Sponsor
- The University of Adelaide
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1500
Women with a singleton pregnancy less than 12 weeks’ gestation attending the first antenatal clinic, their partners and babies
Women with,
1. Multiple pregnancy
2. Major fetal anomalies
3. Known essential hypertension pre-pregnancy, whether or
not on anti hypertensive medication OR
Women who are not known to have hypertension, but have
severe hypertension (blood pressure greater than 160/110mmHg) at booking
4. Type I or II diabetes
5. Renal disease
6. Systemic lupus erythematosus and anti-phospholipid
syndrome
7. Known major uterine anomaly
8. Cervical cone biopsy
9. More than 3 miscarriages more than 3 terminations
10. Treatment with low dose aspirin, calcium greater than 1g/24h, heparin, low molecular weight heparin, antioxidants (vitamin C and E) in a trial setting
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method